Rick Schafer
Stock Analyst at Oppenheimer
(4.76)
# 119
Out of 5,180 analysts
178
Total ratings
64.02%
Success rate
21.26%
Average return
Main Sectors:
Stocks Rated by Rick Schafer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMTC Semtech | Maintains: Outperform | $100 → $110 | $80.04 | +37.43% | 13 | Mar 17, 2026 | |
| NVDA NVIDIA | Reiterates: Outperform | $265 | $175.75 | +50.78% | 27 | Feb 26, 2026 | |
| ADI Analog Devices | Reiterates: Outperform | $350 → $400 | $320.58 | +24.77% | 24 | Feb 19, 2026 | |
| AVGO Broadcom | Maintains: Outperform | $435 → $450 | $313.49 | +43.55% | 22 | Dec 12, 2025 | |
| MRVL Marvell Technology | Reiterates: Outperform | $115 → $150 | $106.71 | +40.57% | 18 | Dec 3, 2025 | |
| MPWR Monolithic Power Systems | Maintains: Outperform | $700 → $800 | $1,119.51 | -28.54% | 21 | Jul 15, 2025 | |
| VECO Veeco Instruments | Reiterates: Outperform | $40 → $35 | $34.67 | +0.95% | 13 | Feb 7, 2025 | |
| NXPI NXP Semiconductors | Maintains: Outperform | $330 → $300 | $195.58 | +53.39% | 11 | Nov 6, 2024 | |
| TXN Texas Instruments | Maintains: Perform | n/a | $196.30 | - | 8 | Apr 24, 2024 | |
| AKTS Aktis Oncology | Maintains: Outperform | $6 → $3 | $17.07 | -82.43% | 5 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $6 | $1.17 | +412.82% | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $77.07 | - | 4 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $120 | $60.08 | +99.73% | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $268 | $44.63 | +500.49% | 1 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $147.13 | - | 8 | Mar 1, 2017 |
Semtech
Mar 17, 2026
Maintains: Outperform
Price Target: $100 → $110
Current: $80.04
Upside: +37.43%
NVIDIA
Feb 26, 2026
Reiterates: Outperform
Price Target: $265
Current: $175.75
Upside: +50.78%
Analog Devices
Feb 19, 2026
Reiterates: Outperform
Price Target: $350 → $400
Current: $320.58
Upside: +24.77%
Broadcom
Dec 12, 2025
Maintains: Outperform
Price Target: $435 → $450
Current: $313.49
Upside: +43.55%
Marvell Technology
Dec 3, 2025
Reiterates: Outperform
Price Target: $115 → $150
Current: $106.71
Upside: +40.57%
Monolithic Power Systems
Jul 15, 2025
Maintains: Outperform
Price Target: $700 → $800
Current: $1,119.51
Upside: -28.54%
Veeco Instruments
Feb 7, 2025
Reiterates: Outperform
Price Target: $40 → $35
Current: $34.67
Upside: +0.95%
NXP Semiconductors
Nov 6, 2024
Maintains: Outperform
Price Target: $330 → $300
Current: $195.58
Upside: +53.39%
Texas Instruments
Apr 24, 2024
Maintains: Perform
Price Target: n/a
Current: $196.30
Upside: -
Aktis Oncology
Sep 7, 2023
Maintains: Outperform
Price Target: $6 → $3
Current: $17.07
Upside: -82.43%
Jun 9, 2023
Maintains: Outperform
Price Target: $7 → $6
Current: $1.17
Upside: +412.82%
Jan 13, 2022
Downgrades: Perform
Price Target: n/a
Current: $77.07
Upside: -
Dec 20, 2021
Maintains: Outperform
Price Target: $175 → $120
Current: $60.08
Upside: +99.73%
Nov 9, 2021
Maintains: Outperform
Price Target: $329 → $268
Current: $44.63
Upside: +500.49%
Mar 1, 2017
Downgrades: Perform
Price Target: n/a
Current: $147.13
Upside: -